日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The atypical kinase right open reading frame kinase 1 suppresses glioma cell growth through mammalian target of rapamycin inhibition and apoptotic signaling activation

非典型激酶RCR1通过抑制哺乳动物雷帕霉素靶蛋白(mTOR)和激活细胞凋亡信号通路来抑制胶质瘤细胞的生长。

Ji, Daofei; Li, Jicheng; Wang, Peng; Gao, Shangfeng; Li, Wen

The WW domain presents a promising target for the development of PCIF1 agonists in the treatment of glioma.

WW 结构域是开发 PCIF1 激动剂治疗胶质瘤的一个有前景的靶点。

Yin Jiale, Liu Gai, Zhou Yu, Zhou Junbo, Guo Mengzhe, Hu Zhiyuan, Musunuru Preethi Priyanka, Yu Rutong, Meng Qingming, Gao Shangfeng

Application of Multifunctional Metal Nanoparticles in the Treatment of Glioma

多功能金属纳米粒子在胶质瘤治疗中的应用

Ren, Yanhong; Yang, Han; Xu, Duo; Zhang, Zhengkui; Gao, Shangfeng; Yu, Rutong

Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway

撤稿声明:CRM1可逆抑制剂通过阻断NF-κB信号通路增强胶质母细胞瘤细胞对辐射的敏感性。

Liu, Xuejiao; Tu, Yiming; Wang, Yifeng; Zhou, Di; Chong, Yulong; Shi, Lin; Liu, Guanzheng; Zhang, Xu; Wu, Sijin; Li, Huan; Gao, Shangfeng; Niu, Mingshan; Yu, Rutong

Research progress in molecular pathology markers in medulloblastoma

髓母细胞瘤分子病理标志物的研究进展

Zhou, Zixuan; Zhu, Bingxin; Meng, Qingming; Zhang, Tong; Wu, Yihao; Yu, Rutong; Gao, Shangfeng

MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation

MALT1是胶质母细胞瘤的潜在治疗靶点,并在EGFR诱导的NF-κB激活中发挥关键作用。

Liu, Xuejiao; Yue, Chenglong; Shi, Lin; Liu, Guanzheng; Cao, Qiyu; Shan, Qianqian; Wang, Yifeng; Chen, Xiangyu; Li, Huan; Wang, Jie; Gao, Shangfeng; Niu, Mingshan; Yu, Rutong

Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling

CAPON长链过表达对胶质瘤细胞增殖的影响依赖于AKT/mTOR/P53信号通路

Liang, Dong; Song, Yunnong; Fan, Guangwei; Ji, Daofei; Zhang, Tong; Nie, Er; Liu, Xuejiao; Liang, Jun; Yu, Rutong; Gao, Shangfeng

PHAP1 promotes glioma cell proliferation by regulating the Akt/p27/stathmin pathway

PHAP1通过调控Akt/p27/stathmin通路促进胶质瘤细胞增殖。

Xie, Manyi; Ji, Zhe; Bao, Yaxing; Zhu, Yufu; Xu, Yang; Wang, Lei; Gao, Shangfeng; Liu, Zhiyi; Tian, Zilu; Meng, Qingming; Shi, Hengliang; Yu, Rutong

Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway

RASD1 过表达抑制胶质瘤细胞迁移/侵袭并使 AKT/mTOR 信号通路失活

Gao, Shangfeng; Jin, Lei; Liu, Guangping; Wang, Peng; Sun, Zonghan; Cao, Yujia; Shi, Hengliang; Liu, Xuejiao; Shi, Qiong; Zhou, Xiuping; Yu, Rutong

FoxR2 promotes glioma proliferation by suppression of the p27 pathway.

FoxR2 通过抑制 p27 通路促进胶质瘤增殖

Liu Xuejiao, Liu Ning, Yue Chenglong, Wang Dacheng, Qi Zhenglei, Tu Yiming, Zhuang Guokun, Zhou Di, Gao Shangfeng, Niu Mingshan, Yu Rutong